Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
170 hedge funds and large institutions have $591M invested in Avid Bioservices, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 52 increasing their positions, 72 reducing their positions, and 19 closing their positions.
11% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 19
9% more call options, than puts
Call options by funds: $105K | Put options by funds: $96K
1% more funds holding
Funds holding: 169 → 170 (+1)
28% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 72
35% less capital invested
Capital invested by funds: $907M → $591M (-$316M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$11.2M |
| 2 |
PCM
Palisade Capital Management
Fort Lee,
New Jersey
|
+$6.34M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$5.9M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.35M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$2.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$17.4M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$12.4M |
| 3 |
Jennison Associates
New York
|
-$9.88M |
| 4 |
AC
AltraVue Capital
Bellevue,
Washington
|
-$8.69M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$8.52M |
CDMO Hedge Fund Activity: Q3 2023 in Review
170 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q3 2023, worth a combined $591M — down 35% from $907M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new CDMO positions and 19 closed out — a net gain of 2 holders — while 52 added to existing stakes and 72 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $11.2M. The largest seller was Fidelity Investments, cutting an estimated $17.4M.
- 170 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q3 2023, up from 169 in Q2 2023.
- Funds reported $591M of Avid Bioservices, Inc. Common Stock stock for Q3 2023, down 35% quarter-over-quarter.
- 21 funds opened new Avid Bioservices, Inc. Common Stock positions in Q3 2023 and 19 closed out, a net change of +2 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q3 2023 was Citadel Advisors, an estimated $11.2M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q3 2023 was Fidelity Investments, an estimated $17.4M sold.
Based on aggregated 13F filings for Q3 2023.